quinpirole has been researched along with Dyskinesia, Medication-Induced in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Blass, BE; Bohmann, J; Chen, PJ; Daadi, ES; Daadi, EW; Daadi, MM; Kim, J; Oh, T; Roy-Choudhury, G | 1 |
| Cheng, L; Li, L; Wang, Y | 1 |
| Abbaszadeh, M; Andreoli, L; Cao, X; Cenci, MA | 1 |
| Bartlett, MJ; Falk, T; Flores, AJ; Heien, ML; Parent, KL; Polt, R; Porreca, F; Root, BK; Sherman, SJ | 1 |
| Cruz, AV; Delaville, C; Dupre, KB; Eyring, KW; Gerber, CM; McCoy, AJ; Walters, JR | 1 |
| Bédard, PJ; Grégoire, L; Samadi, P | 1 |
| Meredith, GE; Napier, TC; Switzer, RC | 1 |
| Axelrod, JD; Barghshoon, S; Chen, CK; Cheyette, BN; Ebert, J; Kovoor, A; Lester, HA; Schwarz, J; Schwarz, S; Seyffarth, P; Simon, MI | 1 |
| LaHoste, GJ; Marshall, JF | 1 |
| Gerlach, J; Lublin, H; Mørkeberg, F | 1 |
| Gerlach, J; Peacock, L | 1 |
| Bédard, PJ; Britton, DR; Grondin, R; Shiosaki, K | 1 |
| Joyce, JN; Neal-Beliveau, BS | 1 |
| Adachi, K; Cools, AR; Hasegawa, M; Hirose, N; Ikeda, H; Koshikawa, N; Sato, M | 1 |
| Jackson, MJ; Jenner, P; Kanda, T; Kase, H; Kuwana, Y; Nakamura, J; Pearce, RK; Smith, LA | 1 |
| Andringa, G; Cools, AR; Drukarch, B; Renier, WO; Stoof, JC; Vermeulen, RJ | 1 |
| Jenner, P; Smith, LA; Treseder, SA | 1 |
| Gerlach, J; Lublin, H; Peacock, L | 2 |
| Eichelman, B; Pucilowski, O | 1 |
| Bédard, PJ; Boucher, R | 1 |
| Schneider, JS | 1 |
| Egawa, M; Friedhoff, AJ; Rosengarten, H; Schweitzer, JW | 1 |
| Gerlach, J; Lublin, H | 1 |
| Ellison, G; Gunne, L; Johansson, P; Levin, E | 1 |
| Gerlach, J; Kistrup, K; Korsgaard, S | 1 |
26 other study(ies) available for quinpirole and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease.
Topics: Animals; Antiparkinson Agents; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Ligands; Parkinsonian Disorders; Primates; Protein Structure, Secondary; Quinpirole; Receptors, Dopamine D3 | 2022 |
Differential roles of two isoforms of dopamine D2 receptors in l-dopa-induced abnormal involuntary movements in mice.
Topics: Animals; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Mice, Knockout; Motor Activity; Protein Isoforms; Quinpirole; Receptors, Dopamine D2; Salicylamides | 2021 |
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzimidazoles; Dyskinesia, Drug-Induced; Dystonia; Mice; Movement; Oxidopamine; Parkinsonian Disorders; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia.
Topics: Animals; Antiparkinson Agents; Benzazepines; Dizocilpine Maleate; Drug Synergism; Dyskinesia, Drug-Induced; Glycopeptides; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Quinpirole; Rats | 2018 |
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Gamma Rhythm; Levodopa; Male; Motor Activity; Motor Cortex; Neurons; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 2016 |
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Dopamine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Endorphins; Female; Levodopa; Macaca fascicularis; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 2003 |
Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Immunohistochemistry; Male; Microscopy, Electron; Nerve Degeneration; Presynaptic Terminals; Prosencephalon; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2004 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Mice; Mice, Knockout; Movement Disorders; Parkinson Disease; Patch-Clamp Techniques; Protein Interaction Mapping; Protein Structure, Tertiary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reserpine; RGS Proteins; Subcellular Fractions; Sulpiride; Transfection | 2005 |
Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Caudate Nucleus; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Gene Expression; Genes, fos; Globus Pallidus; Immunohistochemistry; Male; Neostriatum; Putamen; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine | 1994 |
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzofurans; Cebus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Ergolines; Grooming; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1994 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinolones; Quinpirole; Receptors, Dopamine D1; Thiophenes | 1997 |
Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Corpus Striatum; Critical Period, Psychological; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Grooming; Male; Motor Activity; Mouth; Observation; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Self-Injurious Behavior; Stereotyped Behavior | 1998 |
Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Clozapine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Jaw; Male; Mastication; Quinpirole; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Serotonin Antagonists | 1999 |
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Callithrix; Carbidopa; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Intraperitoneal; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Purines; Quinpirole; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2000 |
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.
Topics: Animals; Arm; Behavior, Animal; Benzazepines; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography; Macaca mulatta; Male; Motor Activity; Movement; MPTP Poisoning; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Reproducibility of Results | 1999 |
Endogenous dopaminergic tone and dopamine agonist action.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Benzopyrans; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Levodopa; Locomotion; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2000 |
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome | 1992 |
Diltiazem suppresses quinpirole-induced oral stereotypies in haloperidol withdrawn rats.
Topics: Analysis of Variance; Animals; Diltiazem; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance Withdrawal Syndrome | 1991 |
The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment.
Topics: Animals; Antipsychotic Agents; Benzazepines; Blinking; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Grooming; Hypnotics and Sedatives; Male; Quinpirole; Raclopride; Receptors, Dopamine; Salicylamides; Substance Withdrawal Syndrome | 1990 |
Effect of D1 receptor stimulation in normal and MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Ergolines; Female; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1989 |
Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ergolines; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Quinpirole | 1989 |
Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dyskinesia, Drug-Induced; Ergolines; Fluphenazine; Male; Quinolines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior | 1988 |
Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dyskinesia, Drug-Induced; Ergolines; Female; Haloperidol; Quinpirole; Receptors, Dopamine | 1988 |
Opposite effects of a D1 and a D2 agonist on oral movements in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dyskinesia, Drug-Induced; Ergolines; Female; Mouth; Movement; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acute Disease; Animals; Benzazepines; Biperiden; Cebus; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Male; Quinpirole; Raclopride; Receptors, Dopamine; Salicylamides | 1987 |